REGN
Regeneron Pharmaceuticals Inc
742.10$
+0.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| 60.0 | 48.3 | 46.4 | 49.4 | 40.9 | 36.5 | 27.7 | 24.8 | 25.9 | 17.5 | 19.5 | 17.4 | 14.8 | 20.3 | 24.7 | 24.6 | 20.2 | 15.4 | 13.1 | 10.0 | 9.9 | 8.9 | 10.0 | 11.8 | 14.5 | 19.0 | 22.4 | 19.0 | 23.4 | 25.3 | 28.7 | 28.1 | 26.2 | 18.4 | 15.7 | 12.8 | 13.2 | 18.4 | 18.8 | 15.4 | |
| 9.9 | 8.7 | 9.0 | 10.9 | 9.5 | 7.4 | 6.5 | 6.4 | 7.3 | 6.4 | 7.2 | 5.5 | 4.8 | 6.5 | 8.0 | 10.0 | 8.0 | 6.4 | 5.7 | 5.0 | 5.1 | 4.4 | 4.8 | 4.7 | 5.7 | 6.8 | 7.6 | 6.5 | 7.1 | 7.6 | 8.5 | 9.0 | 8.8 | 5.7 | 5.0 | 4.0 | 4.2 | 5.8 | 5.6 | 4.3 | |
| 10.4 | 9.6 | 9.2 | 10.3 | 8.6 | 7.1 | 6.0 | 5.5 | 5.9 | 4.9 | 5.0 | 3.7 | 3.0 | 3.9 | 4.6 | 8.1 | 6.3 | 4.9 | 4.4 | 4.1 | 4.0 | 3.8 | 4.0 | 3.3 | 3.6 | 3.6 | 4.0 | 3.4 | 3.7 | 3.8 | 4.1 | 4.3 | 4.2 | 2.8 | 2.4 | 1.9 | 1.9 | 2.7 | 2.6 | 2.1 | |
| 9.9 | 8.7 | 8.9 | 11.0 | 9.6 | 7.5 | 6.5 | 6.4 | 7.2 | 6.2 | – | – | – | 6.3 | 7.9 | 9.9 | 8.3 | 6.5 | 5.8 | 5.0 | 5.0 | 4.4 | 4.7 | 4.7 | 5.6 | 6.7 | 7.4 | 6.5 | 7.1 | 7.6 | 8.4 | 9.0 | 8.8 | 5.7 | 4.9 | 4.0 | 4.2 | 5.7 | 5.6 | 4.3 | |
| 35.7 | 29.6 | 28.6 | 31.8 | 26.1 | 19.6 | 16.4 | 15.7 | 17.7 | 15.2 | – | – | – | 15.6 | 19.7 | 20.9 | 17.5 | 13.6 | 11.4 | 8.3 | 8.1 | 7.4 | 8.2 | 10.0 | 11.9 | 15.6 | 18.0 | 15.6 | 19.2 | 21.1 | 24.2 | 23.8 | 22.2 | 15.1 | 12.6 | 10.5 | 10.5 | 14.1 | 14.4 | 11.5 | |
| 56.0 | 44.2 | 33.7 | 58.2 | 65.2 | 42.2 | 31.2 | 24.1 | 28.6 | 23.7 | 22.6 | 18.9 | 15.9 | 21.5 | 33.0 | 30.3 | 40.3 | 27.1 | 25.8 | 36.5 | 12.8 | 10.9 | 10.0 | 8.6 | 15.3 | 18.6 | 25.6 | 19.7 | 20.3 | 26.2 | 27.9 | 37.8 | 36.2 | 22.5 | 23.4 | 14.8 | 14.5 | 20.3 | 20.0 | 18.9 | |
| 1.8% | 2.3% | 3.0% | 1.7% | 1.5% | 2.4% | 3.2% | 4.1% | 3.5% | 4.2% | 4.4% | 5.3% | 6.3% | 4.7% | 3.0% | 3.3% | 2.5% | 3.7% | 3.9% | 2.7% | 7.8% | 9.1% | 10.0% | 11.7% | 6.5% | 5.4% | 3.9% | 5.1% | 4.9% | 3.8% | 3.6% | 2.6% | 2.8% | 4.4% | 4.3% | 6.7% | 6.9% | 4.9% | 5.0% | 5.3% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 92.3% | 92.7% | 92.6% | 91.7% | 90.8% | 90.8% | 90.6% | 91.0% | 91.2% | 91.3% | 90.0% | 88.9% | 87.0% | 85.1% | 85.4% | 84.3% | 84.7% | 84.0% | 84.2% | 84.8% | 84.6% | 83.1% | 82.9% | 82.9% | 83.1% | 85.5% | 85.1% | 84.4% | 83.9% | 83.0% | 83.9% | 84.5% | 85.3% | 86.1% | 85.8% | 85.6% | 85.4% | 85.4% | 84.5% | 84.9% | |
| 25.7% | 27.4% | 28.8% | 32.3% | 34.2% | 35.4% | 36.5% | 36.9% | 37.0% | 37.8% | 37.2% | 32.7% | 34.0% | 33.7% | 34.6% | 37.5% | 38.9% | 42.1% | 43.4% | 53.9% | 55.2% | 55.7% | 55.2% | 49.8% | 47.1% | 42.2% | 39.2% | 36.0% | 34.7% | 32.6% | 30.8% | 30.3% | 29.3% | 28.1% | 27.2% | 27.0% | 25.9% | 24.9% | 24.3% | 25.6% | |
| 16.5% | 18.1% | 19.3% | 22.1% | 23.2% | 20.4% | 23.5% | 25.7% | 28.2% | 36.4% | 36.9% | 31.6% | 32.4% | 32.3% | 32.5% | 40.4% | 39.8% | 41.3% | 43.5% | 50.1% | 51.7% | 50.2% | 48.1% | 40.0% | 39.2% | 35.6% | 33.8% | 33.9% | 30.5% | 30.1% | 29.4% | 32.0% | 33.6% | 31.1% | 31.9% | 31.4% | 32.1% | 31.4% | 29.6% | 27.9% | |
| 17.7% | 19.8% | 26.6% | 18.7% | 14.5% | 17.6% | 20.9% | 26.4% | 25.6% | 27.0% | 31.9% | 29.1% | 30.1% | 30.5% | 24.3% | 32.8% | 19.9% | 23.6% | 22.1% | 13.7% | 39.7% | 40.6% | 48.1% | 55.3% | 37.0% | 36.3% | 29.5% | 32.8% | 35.2% | 29.1% | 30.3% | 23.8% | 24.4% | 25.3% | 21.4% | 27.0% | 29.2% | 28.4% | 27.9% | 22.7% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| 17.4% | 19.8% | 19.8% | 20.9% | 21.1% | 19.5% | 21.7% | 22.1% | 22.8% | 27.9% | 25.7% | 21.2% | 20.4% | 19.1% | 18.8% | 32.9% | 31.2% | 31.9% | 33.4% | 41.0% | 40.5% | 43.0% | 39.8% | 27.5% | 25.0% | 19.1% | 17.8% | 17.9% | 16.0% | 15.2% | 14.3% | 15.3% | 15.9% | 15.0% | 15.3% | 14.9% | 14.8% | 14.4% | 14.1% | 13.7% | |
| 11.4% | 12.6% | 12.3% | 14.2% | 14.7% | 13.7% | 15.2% | 16.0% | 16.6% | 20.8% | 18.9% | 15.7% | 15.4% | 14.3% | 14.5% | 20.7% | 19.6% | 20.5% | 22.5% | 28.9% | 29.6% | 31.7% | 30.1% | 20.9% | 19.4% | 14.9% | 13.9% | 14.0% | 12.4% | 12.0% | 11.2% | 12.0% | 12.4% | 11.7% | 12.0% | 11.7% | 11.4% | 11.1% | 10.8% | 10.4% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 52 | -54 | -104 | 522 | 575 | 360 | -315 | 87 | -381 | -1,377 | – | – | – | -1,312 | -1,065 | -492 | 1,708 | 1,416 | 1,259 | 625 | -734 | -186 | -1,365 | -694 | -1,510 | -405 | -1,935 | 45 | -170 | -747 | -619 | 63 | -28 | -504 | -1,105 | -11 | -521 | -1,094 | -256 | -469 | |
| 0.0 | 0.0 | -0.1 | 0.3 | 0.3 | 0.2 | -0.1 | 0.0 | -0.1 | -0.5 | – | – | – | -0.5 | -0.4 | -0.1 | 0.5 | 0.3 | 0.3 | 0.1 | -0.1 | 0.0 | -0.1 | -0.1 | -0.2 | -0.1 | -0.4 | 0.0 | 0.0 | -0.2 | -0.1 | 0.0 | 0.0 | -0.1 | -0.2 | 0.0 | -0.1 | -0.2 | 0.0 | -0.1 | |
| 65.8% | 63.8% | 62.2% | 68.1% | 69.5% | 70.1% | 70.1% | 72.2% | 72.8% | 74.6% | 73.5% | 74.1% | 75.4% | 74.9% | 77.0% | 62.8% | 63.0% | 64.2% | 67.4% | 70.4% | 72.9% | 73.8% | 75.6% | 76.0% | 77.5% | 77.6% | 78.2% | 78.3% | 77.4% | 78.5% | 78.5% | 78.2% | 78.3% | 77.7% | 78.3% | 78.3% | 77.1% | 77.1% | 76.9% | 76.0% | |
| 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | – | – | – | 0.0 | 0.1 | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| 6.70 | 7.60 | 8.36 | 9.94 | 10.92 | 10.31 | 12.42 | 13.90 | 15.62 | 21.29 | 21.01 | 18.00 | 18.76 | 18.51 | 19.80 | 25.30 | 27.70 | 31.31 | 36.23 | 56.01 | 61.42 | 71.34 | 70.15 | 49.88 | 47.61 | 38.06 | 36.69 | 37.74 | 35.19 | 34.74 | 33.52 | 37.45 | 40.06 | 38.78 | 40.46 | 41.06 | 42.71 | 41.91 | 41.07 | 40.53 | |
| 40.56 | 41.98 | 43.20 | 45.09 | 47.14 | 50.53 | 52.78 | 54.17 | 55.30 | 58.46 | 56.87 | 56.91 | 57.95 | 57.36 | 60.93 | 62.65 | 69.66 | 75.72 | 83.22 | 111.77 | 118.90 | 141.98 | 145.96 | 124.80 | 121.54 | 106.78 | 108.51 | 111.24 | 115.50 | 115.27 | 113.81 | 116.89 | 119.17 | 124.80 | 126.67 | 130.89 | 132.91 | 133.42 | 138.53 | 145.46 | |
| 38.50 | 38.43 | 42.22 | 47.54 | 51.71 | 52.87 | 57.16 | 62.76 | 68.36 | 76.28 | 81.73 | 84.88 | 91.93 | 97.01 | 105.41 | 76.82 | 88.86 | 98.25 | 108.36 | 136.53 | 151.52 | 165.80 | 176.08 | 181.47 | 190.06 | 198.81 | 206.10 | 210.87 | 219.62 | 228.23 | 234.50 | 244.42 | 252.37 | 257.94 | 264.28 | 275.68 | 288.79 | 290.76 | 291.77 | 296.92 | |
| 7.18 | 8.30 | 11.51 | 8.44 | 6.86 | 8.90 | 11.04 | 14.29 | 14.14 | 15.78 | 18.13 | 16.59 | 17.46 | 17.50 | 14.82 | 20.57 | 13.89 | 17.85 | 18.36 | 15.28 | 47.25 | 57.68 | 70.17 | 69.02 | 44.99 | 38.81 | 32.06 | 36.46 | 40.61 | 33.51 | 34.53 | 27.80 | 29.07 | 31.61 | 27.16 | 35.40 | 38.75 | 37.96 | 38.58 | 32.98 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.